Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sophie Delhomme"'
Autor:
Alison Luckey, Emilie Alirol, Sophie Delhomme, John O'Donnell, Esther Bettiol, John Mueller, Seamus O'Brien, Jean‐Yves Gillon
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 5, Pp 770-780 (2023)
Abstract Gonorrhea is a sexually transmitted infection for which antibiotic treatment options have declined due to increasing antibiotic resistance. Zoliflodacin, an investigational oral spiropyrimidinetrione antibiotic with activity against Neisseri
Externí odkaz:
https://doaj.org/article/06e6f3f90fcb4202b94a93a19b09741c
Autor:
Victor Kande Betu Ku Mesu, DPH, Wilfried Mutombo Kalonji, MD, Clélia Bardonneau, MSc, Olaf Valverde Mordt, MSc, Digas Ngolo Tete, MPH, Séverine Blesson, MSc, François Simon, MSc, Sophie Delhomme, MSc, Sonja Bernhard, PhD, Hélène Mahenzi Mbembo, MD, Christian Mpia Moke, MD, Steven Lumeya Vuvu, MMed, Junior Mudji E'kitiak, MD, Felix Akwaso Masa, MD, Melchias Mukendi Ilunga, MD, Dieudonné Mpoyi Muamba Nzambi, MD, Tim Mayala Malu, MD, Serge Kapongo Tshilumbwa, MD, Franck Botalema Bolengi, MD, Mathieu Nkieri Matsho, MD, Crispin Lumbala, MPH, Bruno Scherrer, PhD, Nathalie Strub-Wourgaft, MD, Antoine Tarral, MD
Publikováno v:
The Lancet Global Health, Vol 9, Iss 7, Pp e999-e1008 (2021)
Summary: Background: Staging and treatment of human African trypanosomiasis caused by Trypanosoma brucei gambiense (g-HAT) required lumbar puncture to assess cerebrospinal fluid (CSF) and intravenous drugs that cross the blood–brain barrier for lat
Externí odkaz:
https://doaj.org/article/fc53e144d24e4957ad24602246c04574
Autor:
Alison Luckey, Emilie Alirol, Sophie Delhomme, John O'Donnell, Esther Bettiol, John Mueller, Seamus O'Brien, Jean‐Yves Gillon
Publikováno v:
Clinical and Translational Science. 16:770-780
Autor:
Antoine Tarral, Lionel Hovsepian, Thierry Duvauchelle, Yves Donazzolo, Mathilde Latreille, Mathieu Felices, Virginie Gualano, Sophie Delhomme, Olaf Valverde Mordt, Severine Blesson, Pascal Voiriot, Nathalie Strub-Wourgaft
Publikováno v:
Clinical Pharmacokinetics. 62:481-491
Autor:
Hélène Mahenzi Mbembo, Mathieu Nkieri Matsho, Bruno Scherrer, Steven Lumeya Vuvu, Wilfried Mutombo Kalonji, Franck Botalema Bolengi, Olaf Valverde Mordt, Sonja Bernhard, Sophie Delhomme, Séverine Blesson, Antoine Tarral, Tim Mayala Malu, Clélia Bardonneau, Serge Kapongo Tshilumbwa, Dieudonné Mpoyi Muamba Nzambi, Felix Akwaso Masa, François Simon, Melchias Mukendi Ilunga, Crispin Lumbala, Digas Ngolo Tete, Nathalie Strub-Wourgaft, Victor Kande Betu Ku Mesu, Christian Mpia Moke, Junior Mudji E'kitiak
Publikováno v:
The Lancet. Global Health
The Lancet Global Health, Vol 9, Iss 7, Pp e999-e1008 (2021)
The Lancet Global Health, Vol 9, Iss 7, Pp e999-e1008 (2021)
Summary Background Staging and treatment of human African trypanosomiasis caused by Trypanosoma brucei gambiense (g-HAT) required lumbar puncture to assess cerebrospinal fluid (CSF) and intravenous drugs that cross the blood–brain barrier for late-
Autor:
Victor Kande Betu Kumesu, Wilfried Mutombo Kalonji, Clélia Bardonneau, Olaf Valverde Mordt, Digas Ngolo Tete, Séverine Blesson, François Simon, Sophie Delhomme, Sonja Bernhard, Pathou Nganzobo Ngima, Hélène Mahenzi Mbembo, Jean-Pierre Fina Lubaki, Steven Lumeya Vuvu, Willy Kuziena Mindele, Médard Ilunga Wa Kyhi, Guylain Mandula Mokenge, Lewis Kaninda Badibabi, Augustin Kasongo Bonama, Papy Kavunga Lukula, Crispin Lumbala, Bruno Scherrer, Nathalie Strub-Wourgaft, Antoine Tarral
Publikováno v:
The Lancet. Global health. 10(11)
BACKGROUND: Fexinidazole has been reported as an effective oral monotherapy against non-severe gambiense human African trypanosomiasis in a recent trial in adults. We aimed to assess the safety and efficacy of fexinidazole in children across all dise
Autor:
Sabine Specht, Natalie Strub-Wourgaft, Heino Stass, Belen Pedrique, Jeremy Dennison, Karen Dequatre-Cheeseman, Frans van den Berg, Sophie Delhomme, Frédéric Monnot, Claudia Peña-Rossi, Susanne Skrabs, Jean-Yves Gillon, Maria-Luisa Rodriguez
Aims: Emodepside is an anthelmintic, originally developed for veterinary use. We investigated the safety, pharmacokinetics, relative bioavailability and dose linearity of four oral formulations of emodepside in healthy male subjects. Methods: Three r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f70ac7813971a74eb5028e30b0fa036b
https://doi.org/10.22541/au.159863472.25422049
https://doi.org/10.22541/au.159863472.25422049
Autor:
Bruno Scherrer, Victor Kande Betu Ku Mesu, Crispin Lumbala, Olaf Valverde Mordt, Nathalie Strub-Wourgaft, Wilfried Mutombo Kalonji, Séverine Blesson, Willy Kuziena, Jean Pierre Fina Lubaki, Steven Lumeya Vuvu, Pathou Nganzobo Ngima, Augustin Kasongo Bonama, François Simon, Lewis Kaninda Badibabi, Jean Louis Lumaliza Solomo, Medard Ilunga, Sonja C. Bernhard, Francis Regongbenga Dama, Josué Amici Heradi, Guylain Mandula, Papy Kavunga Lukula, Clélia Bardonneau, Hélène Mahenzi Mbembo, Digas Ngolo Tete, Sophie Delhomme, Antoine Tarral
Publikováno v:
The Lancet. 391:144-154
Summary Background Few therapeutic options are available to treat the late-stage of human African trypanosomiasis, a neglected tropical disease, caused by Trypanosoma brucei gambiense (g-HAT). The firstline treatment is a combination therapy of oral
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 56, No 3 (2003) pp. 327-336
The formulation of a new GnRH antagonist (degarelix) in biodegradable poly(DL-lactide-co-glycolide) (PLGA) microparticles was investigated for the development of a 3-month sustained release formulation to treat prostate cancer. The aim was to screen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::128a4a6185f76abc0bd27ee0211c7fd3
https://archive-ouverte.unige.ch/unige:84848
https://archive-ouverte.unige.ch/unige:84848